Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients

被引:203
作者
Pelaez-Luna, Mario
Chari, Suresh T.
Smyrk, Thomas C.
Takahashi, Naoki
Clain, Jonathan E.
Levy, Michael J.
Pearson, Randall K.
Petersen, Bret T.
Topazian, Mark D.
Vege, Santhi S.
Kendrick, Michael
Farnell, Michael B.
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Pathol, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA
[4] Mayo Clin, Coll Med, Div Gastroenterol & Gen Surg, Rochester, MN 55905 USA
关键词
D O I
10.1111/j.1572-0241.2007.01224.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Recent consensus guidelines suggest that presence of >= 1 of the following is an indication for resection (IR) of branch duct intraductal papillary mucinous neoplasm (IPMN-Br): cyst-related symptoms, main pancreatic duct diameter >= 10 mm, cyst size >= 30 mm, intramural nodules, or cyst fluid cytology suspicious/positive for malignancy. Among a cohort of patients with IPMN-Br we determined if the consensus IR (CIR), presence of multifocal IPMN-Br, or growth of cyst size on follow-up predict malignancy. Methods: We identified 147 patients with IPMN-Br of whom 66 underwent surgical resection at diagnosis and 81 were followed conservatively, of whom 11 were resected during follow-up. Clinical, imaging, histological, and cyst fluid characteristics from all 147 patients with IPMN-Br were obtained from clinical records and/or by contacting the patients. In all cases, presence of CIR at baseline and during follow-up (N = 66), presence of multifocal cysts (N = 57), and increase in cyst size (N = 38) were noted. Results: Among the 77 resected IPMN-Brs, at initial evaluation 61 had at least one CIR and 16 had none. Malignancy was present in 9/61 (15%) with CIR and 0/16 without IR (P = 0.1). When presence of any one of the CIR was taken as an indicator of malignancy, the CIR had a sensitivity, specificity, positive predictive value, and negative predictive value of 100%, 23%, 14%, and 100%, respectively. Prevalence of malignancy in those with single versus multifocal IPMN-Br was similar (13% vs 11%). No patient has developed malignancy after a median follow-up of 15 months. So far, none of the 38 patients with increase in cyst size on follow-up has developed malignancy related symptoms. Conclusions: Suggested consensus indications for resection identify all patients with malignancy; however, their specificity is low. In the short term it would be safe to follow patients without these features.
引用
收藏
页码:1759 / 1764
页数:6
相关论文
共 21 条
  • [1] [Anonymous], 2000, WHO Classification of Tumors of the Digestive System
  • [2] Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study
    Brugge, WR
    Lewandrowski, K
    Lee-Lewandrowski, E
    Centeno, BA
    Szydlo, T
    Regan, S
    del Castillo, CF
    Warshaw, AL
    [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1330 - 1336
  • [3] Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas
    Chari, ST
    Yadav, D
    Smyrk, TC
    DiMagno, EP
    Miller, LJ
    Raimondo, M
    Clain, JE
    Norton, IA
    Pearson, RK
    Petersen, BT
    Wiersema, MJ
    Farnell, MB
    Sarr, MG
    [J]. GASTROENTEROLOGY, 2002, 123 (05) : 1500 - 1507
  • [4] Intraductal papillary mucinous tumors of the pancreas
    Conlon, KC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (20) : 4518 - 4523
  • [5] Surgical management of intraductal papillary mucinous tumor of the pancreas
    Doi, R
    Fujimoto, K
    Wada, M
    Imamura, M
    [J]. SURGERY, 2002, 132 (01) : 80 - 85
  • [6] Intraductal papillary mucinous tumor of the pancreas
    Farrell, JJ
    Brugge, WR
    [J]. GASTROINTESTINAL ENDOSCOPY, 2002, 55 (06) : 701 - 714
  • [7] An illustrated consensus on the classification of pancreatic Intraepithelial neoplasia and intraductal papillary mucinous neoplasms
    Hruban, RH
    Takaori, K
    Klimstra, DS
    Adsay, NV
    Albores-Saavedra, J
    Biankin, AV
    Biankin, SA
    Compton, C
    Fukushima, N
    Furukawa, T
    Goggins, M
    Kato, Y
    Klöppel, G
    Longnecker, DS
    Lüttges, J
    Maitra, A
    Offerhaus, GJA
    Shimizu, M
    Yonezawa, S
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (08) : 977 - 987
  • [8] MORPHOLOGIC CHANGES IN THE PANCREAS DETECTED BY SCREENING ULTRASONOGRAPHY IN A MASS SURVEY, WITH SPECIAL REFERENCE TO MAIN DUCT DILATATION, CYST FORMATION, AND CALCIFICATION
    IKEDA, M
    SATO, T
    MOROZUMI, A
    FUJINO, MA
    YODA, Y
    OCHIAI, M
    KOBAYASHI, K
    [J]. PANCREAS, 1994, 9 (04) : 508 - 512
  • [9] Kimura W, 1995, INT J PANCREATOL, V18, P197
  • [10] Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS
    Kobayashi, G
    Fujita, N
    Noda, Y
    Ito, K
    Horaguchi, J
    Takasawa, O
    Akaishi, S
    Tsuchiya, T
    Kobari, M
    [J]. JOURNAL OF GASTROENTEROLOGY, 2005, 40 (07) : 744 - 751